Top Markets
#1 Audiera Audiera +33.84%
#2 TROLL TROLL +33.46%
#3 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.45%
#4 Bitcoin Cash Bitcoin Cash +32.20%
#5 GALA GALA +32.15%
#6 Fabric Protocol Fabric Protocol +31.41%
#7 B3 (Base) B3 (Base) +30.61%
#8 Tutorial Tutorial +28.97%
#9 Kamino Kamino +28.72%
#10 Bless Bless +28.27%
Coin of the day
Audiera Audiera
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Classifica tra le azioni #24454
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Prezzo delle azioni
$0.78611575
Capitalizzazione di mercato
$60.45M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-12.06%
Paese
NO
Scambia Lytix Biopharma AS (LYTIX)

Categoria

Healthcare
Rapporto P/B per Lytix Biopharma AS (LYTIX)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Lytix Biopharma AS, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Lytix Biopharma AS da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH